↓ Skip to main content

Dove Medical Press

Real-World Evaluation of the Safety and Effectiveness of Apixaban

Overview of attention for article published in International Journal of General Medicine, January 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Readers on

mendeley
5 Mendeley
Title
Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study
Published in
International Journal of General Medicine, January 2023
DOI 10.2147/ijgm.s392505
Pubmed ID
Authors

Ghazwa B Korayem, Omar A Alshaya, Nirvana Alnajjar, Ahad Alawad, Rand Alotaibi, Nader Bin Sheraim, Fatemah M Hakami, Ohud S Alsudyyes, Rahaf H Alsoghayer, Lina M Alhushan, Asma H Qudayr, Majed S Al Yami, Omar A Almohammed

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 20%
Unknown 4 80%
Readers by discipline Count As %
Unspecified 1 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 20%
Unknown 3 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2023.
All research outputs
#8,945,522
of 26,560,982 outputs
Outputs from International Journal of General Medicine
#448
of 1,700 outputs
Outputs of similar age
#167,881
of 495,385 outputs
Outputs of similar age from International Journal of General Medicine
#8
of 48 outputs
Altmetric has tracked 26,560,982 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 1,700 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 495,385 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.